The FDA has approved Lilly’s Lyumjev rapid-acting mealtime insulin to reduce high blood sugar after meals and keep blood glucose levels in-range. This approval offers
People at high risk of developing Type 2 diabetes are being fast-tracked into the flagship Healthier You NHS Diabetes Prevention programme following research that revealed
A new therapy that could treat people with diabetes suffering from Covid-19 is undergoing an advanced clinical trial in the UK with the first patient
Imperial College London researchers want to investigate a possible link between Type 1 diabetes and Covid-19 after a small study found cases of Type 1
An economic study has shown the DiRECT programme, which can put Type 2 diabetes in remission for some people, could result in huge savings for
A study has found a connection between traffic noise and obesity. Researchers from the University of Oxford and the University of Leicester found that long-term
New research indicates that nearly half of hospitalised Covid-19 patients without a prior diabetes diagnosis have hyperglycaemia – which is an independent predictor of mortality
A creative project involving people living with Type 1 diabetes and healthcare professionals with a specialism in the condition has provided some welcome respite from
An innovative new vaccine for Type 1 diabetes is being developed, which reverses certain immune responses rather than activating the immune system. “We are trying
A new animated short film discusses the importance of diabetes classification. The video details the differences between Type 1 and Type 2 diabetes, in addition to
